Description

Hexahydro-α-Methyl-2-Oxo-1H-Thieno[3,4-D]Imidazole-4-Valeric Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the synthesis of specialized active pharmaceutical ingredients (APIs) and fine chemicals, where its precise molecular architecture serves as a key building block. It is primarily utilized by research institutions and manufacturers in the pharmaceutical, biotechnology, and agrochemical sectors for developing novel therapeutic agents and high-value specialty products.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex, biologically active molecules and proprietary APIs.
• Bioconjugation & Probe Development: Used in research for creating labeled compounds, molecular probes, and diagnostic agents due to its reactive functional groups.
• Agrochemical Research: Serves as a building block for developing new crop protection agents and specialty pesticides.
• Peptide Mimetics & Drug Design: Integral in medicinal chemistry for constructing peptide analogs and designing novel drug candidates with improved pharmacokinetic properties.
• Chemical Biology Studies: Employed in exploring enzyme mechanisms and protein-ligand interactions as a specialized scaffold.
• Fine Chemical Synthesis: Used in multi-step organic synthesis to introduce specific heterocyclic motifs into target molecules.

Basic Information

Product Name	Hexahydro-α-Methyl-2-Oxo-1H-Thieno[3,4-D]Imidazole-4-Valeric Acid
CAS No.	30868-27-0
Molecular Formula	C11H16N2O3S
Molecular Weight	256.32 g/mol
Synonyms	4-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)valeric acid, α-Methyl derivative of biotin sulfone, Tetrahydro-2-oxothieno[3,4-d]imidazoline-4-valeric acid derivative, Biotin intermediate, 3,4-Dihydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid, 30868-27-0, Thienoimidazole valeric acid derivative
EINECS	Contact for details

Quality Control

Our Hexahydro-α-Methyl-2-Oxo-1H-Thieno[3,4-D]Imidazole-4-Valeric Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, identity confirmation via IR and NMR, and residual solvent analysis, to ensure it meets the stringent requirements for pharmaceutical R&D and GMP-grade synthesis. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept sealed under dry, inert conditions to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.